Swertisin


CAS No. : 6991-10-2

6991-10-2
Price and Availability of CAS No. : 6991-10-2
Size Price Stock
1mg $80 In-stock
5mg $320 In-stock
10 mg Get quote
50 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-N2189
M.Wt: 446.40
Formula: C22H22O10
Purity: >98 %
Solubility: DMSO : 50 mg/mL (ultrasonic)
Introduction of 6991-10-2 :

Swertisin is an oral adenosine A1 receptor antagonist and an SGLT2 inhibitor. Swertisin has anti-diabetic, antioxidant properties, inhibits HBV, and improves cognitive and memory impairments in mice[1][2][3]. In Vitro:Swertisin (7.5 μg/mL, 0-12 h) inhibits glucose uptake in HEK293 cells and reduces the expression of SGLT2[2].
Swertisin (0.2-5 μM, 6-12 days) suppresses levels of HBsAg, HBeAg and HBV DNA in HepG2.2.15 and HBV-infected HepG2-NTPC cells[3]. In Vivo:Swertisin (30 mg/kg, orally, single dose) helps improve symptoms of schizophrenia in mice, including sensory motor gating disruptions and cognitive impairments[1].
Swertisin (2.5 mg/kg, intraperitoneally, once daily, days) reduces the expression of SGLT2 in mouse kidney tissue and can quickly lower blood sugar[2].
Swertisin (0-10 mg/kg, intraperitoneally, every other day, 20 days) significantly inhibits HBV replication in a HBV transgenic mouse model[3].

Your information is safe with us.